Anemia no doente oncológico

Feliciano, Amélia; Costa, Agostinho; Melo, Maria José

doi:10.1016/S0873-2159(15)30664-4

Article information

RESUMO

No presente artigo de revisão os autores analisam os principais mecanismos da anemia no doente oncológico, a sua metodologia diagnóstica e as opções terapêuticas, nomeadamente as indicações da transfusão de concentrado eritrocitário e da utilização da eritropoietina recombinante. É também discutido o impacto da anemia na qualidade de vida dos doentes, na evolução e no tratamento da doença oncológica.

REV PORT PNEUMOL 2003; IX (2): 117-128

Palavras-chave:

Anemia

neoplasia

quimioterapia

radioterapia

qualidade de vida

RhEPO

ABSTRACT

In this paper the authors reviews the anaemia in cancer patients, its mechanisms, diagnosis, and therapeutics, especially the indications for blood transfusion and the use of recombinant human erythropoietin. Also, the author reviews the impact of anaemia in quality of life and in the outcome of therapy and of cancer itself.

REV PORT PNEUMOL 2003; IX (2): 117-128

Key-words:

Anaemia

cancer

chemotherapy

radiotherapy

quality of life

RhEPO

Full text is only aviable in PDF

BIBLIOGRAFIA

[1.]

E. Teixeira.

Factores de Crescimento Hematopoiético no Cancro do Pulmão.

Rev Port Pneumol, V (1999), pp. 192-211

[2.]

M.B. Parente.

Anemia e Cancro do Pulmão.

Rev Port Pneumol, II (1996), pp. 133-139

[3.]

P. Sweeney, D. Nicolae, L. Iguacio, et al.

Effect of Subcutaneous Recombinant Human Erythropoietin in Cancer Patients Receiving Radiotherapy: Final Report of a Randomized Open-Labelled, Phase II Trial.

Br J Cancer, 77 (1998), pp. 1996-2002

Medline

[4.]

S. Soignet.

Management of Cancer-Related Anemia: Epoetin Alfa and Quality of Life.

Semin Hematol, 37 (2000), pp. 9-13

Medline

[5.]

S. Mercadante, V. Gebbia, A. Marrazzo, et al.

Anaemia in Cancer: pathophysiology and treatment.

Cancer Treat Rev, 26 (2000), pp. 303-311

http://dx.doi.org/10.1053/ctrv.2000.0181 | Medline

[6.]

G. Demetri, M. Kris, J. Wade, et al.

Quality-of-life in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study.

Clin Oncol, 16 (1998), pp. 3412-3425

[7.]

SILVER R. The Anemia of Malignancy Issues and treatment. Monografia.

[8.]

M. Grogan, M. Thomas, I. Melamed, et al.

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.

Cancer, 86 (1999), pp. 1528-1535

Medline

[9.]

C. Glaser, W. Millesi, G. Kornek, et al.

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squa mous cell carcinoma of the oral cavity and oropharynx.

Int J Radiat Oncol Biol Phys, 50 (2001), pp. 705-715

Medline

[10.]

P. Kumar.

Tumor Hypoxia and Anemia: Impact on the Efficacy of Radiation Therapy.

Semin Hematol, 3 (2000), pp. 4-8

[11.]

R. Lavey, H. Dempsey.

Erithropoietin increases hemoglobin in cancer patients during radiation therapy.

Int J Radiation Oncology Biol Phys, 27 (1993), pp. 1147-1152

[12.]

T. Littlewood.